Metraipolis › archive › dc_ff38ed7cfe29

Radioligand Therapy in Meningiomas: Today's Evidence, Tomorrow's Possibilities — Europe PMC PMID:41595216

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41595216
DOI
10.3390/cancers18020297
License (as archived)
solo-consultazione
Archived
2026-11-06T17:32:35.111Z
SHA-256 of the archived text
3c39829e0445c114bef4bfd1e267d732f1e11269b28a056b7772b95eccf0f8c0
Stable URL of this page
https://metraipolis.com/documento/dc_ff38ed7cfe29

How to cite

Radioligand Therapy in Meningiomas: Today's Evidence, Tomorrow's Possibilities — Europe PMC PMID:41595216 — Europe PMC (en), https://europepmc.org/article/MED/41595216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff38ed7cfe29 (Metraipolis archive dc_ff38ed7cfe29, sha256 3c39829e0445c114bef4bfd1e267d732f1e11269b28a056b7772b95eccf0f8c0)
BibTeX
@misc{dcff38ed7cfe29,
  title = {Radioligand Therapy in Meningiomas: Today's Evidence, Tomorrow's Possibilities — Europe PMC PMID:41595216},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41595216},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff38ed7cfe29; sha256 3c39829e0445c114bef4bfd1e267d732f1e11269b28a056b7772b95eccf0f8c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595216. Agents can read the archived copy with the MCP tool read_document.